Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (3R,5S) CDHH. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114410599A demonstrates enhanced enzymatic efficiency for rosuvastatin side chains offering substantial cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel carbonyl reductase mutants enable high-yield rosuvastatin intermediate production with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN108486075A details a mutant enzyme for statin side chains, offering enhanced catalytic efficiency and cost reduction in pharmaceutical intermediate manufacturing.